HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-02-17FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
FDA approved a supplemental application for VIRACEPT (nelfinavir mesylate) by Agouron Pharmaceuticals.
-
FDA approval · 2012-02-17FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Norvir (ritonavir) submitted by AbbVie Inc., resulting in an approved update to the drug's l…
-
FDA approval · 2012-02-17FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for Prezista (darunavir) from Janssen Products LP, expanding its approved use in HIV-1 infection.
-
FDA approval · 2012-02-17FDA Approved: APTIVUS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Aptivus (tipranavir) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Observational Study of Treated and Untreated Acute and Early HIV-1 Infection
Clinical trial update describing an observational study comparing outcomes in treated versus untreated individuals with acute and early HIV-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA safety_alert · 2012-02-16European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors
EMA informs about drug interaction between Victrelis (boceprevir) and ritonavir-boosted HIV protease inhibitors, advising clinicians and pat…
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules
A terminated clinical trial evaluating whether an optimized antiretroviral regimen including Enfuvirtide (Fuzeon) plus two active drugs impr…
-
CLINICAL_TRIALS withdrawal · 2012-02-15Clinical Trial Update: Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial [Phase 3]
A Phase 3 trial evaluating EFV-TDF-FTC and AZT-3TC-LPV/r regimens for preventing mother-to-child transmission of HIV in pregnant and breastf…
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) [Phase 2, Phase 3]
A Phase 2/3 study (ANRS 12146 CARINEMO) comparing nevirapine to efavirenz in HIV-TB co-infected patients has completed Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania [NA]
This update reports results from a completed study evaluating whether flash-heating breast milk can reduce mother-to-child transmission of H…
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating the dosage and safety of two intramuscular injections of an …
-
FDA approval · 2012-02-13FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) by Janssen Products LP. The action involves a supplemental NDA approval.
-
CLINICAL_TRIALS withdrawal · 2012-02-09Clinical Trial Update: Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers. [Phase 1]
A Phase 1 trial evaluating safety and pharmacokinetics of escalating oral doses of BI-224436 in healthy male volunteers has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-01-30Clinical Trial Update: Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza
This clinical trial update reports the immune response to the pandemic A/H1N1 influenza vaccine in people with HIV. The study evaluates vacc…
-
CLINICAL_TRIALS trial_result · 2012-01-30Clinical Trial Update: Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED) [Phase 4]
A Phase 4 trial evaluating PegIntron plus ribavirin for chronic hepatitis C in HIV-infected subjects was terminated, with results posted in …
-
CLINICAL_TRIALS trial_result · 2012-01-23Clinical Trial Update: Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection [Phase 2, Phase 3]
Update on a study of Apricitabine, an NRTI for drug-resistant HIV infection; the Phase 2/Phase 3 trial has been terminated.
-
CLINICAL_TRIALS research · 2012-01-23Clinical Trial Update: Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison
A completed clinical trial evaluating surveillance and medical care for HIV-infected intravenous drug users inside and outside the prison sy…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals
A completed clinical trial evaluating interferon-gamma responses to cytomegalovirus infection in HIV-positive individuals.
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Impact of HIV and Its Treatment on Reverse Cholesterol Transport
A completed clinical trial update examining how HIV infection and its treatment affect reverse cholesterol transport.
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History
A completed clinical trial update reporting longitudinal cellular immune responses to Hepatitis B virus and the natural history of infection…
-
CLINICAL_TRIALS withdrawal · 2012-01-20Clinical Trial Update: Predictors of Drug Hypersensitivity in HIV Infected Subjects
A clinical trial titled Predictors of Drug Hypersensitivity in HIV Infected Subjects has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients [Phase 3]
The VERxVE Phase 3 trial compared Nevirapine XR to Nevirapine IR, each with Truvada, in treatment-naive HIV-infected patients; results were …
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy [Phase 2]
A Phase 2 trial comparing three anti-HIV regimens to prevent Nevirapine resistance in pregnant women taking Nevirapine.
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: HIV and STD Prevention for High-Risk, Inner-City, African American Youth [Phase 3]
Phase 3 clinical trial update on HIV and sexually transmitted infection prevention among high-risk inner-city African American youth. The st…
-
CLINICAL_TRIALS withdrawal · 2012-01-19Clinical Trial Update: Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients [Phase 4]
A Phase 4 trial comparing maraviroc versus etravirine in combination antiretroviral therapy for drug-experienced HIV patients co-infected wi…